Good morning, everybody. My name is Kyahn Williamson, SVP of Investor Relations and Corporate Communications at Telix. And we're very pleased to welcome you today to our investor call and webcast to ...
Two recent deaths tied to for-profit clinics in Canada raised concerns about the health effects of having plasma drawn as ...
The company has clearly had success rolling out a variety of useful genAI tools and services. But the enterprise uptake rate ...
A new analysis of Medicare data shows mental health specialists who embraced telehealth did not see substantially more rural ...
There is a legal process in the United States called civil asset forfeiture, and if you drive a truck, carry cash, or run a ...
The Kentucky Derby prep schedule is in full swing, which means it’s time for detailed looks at the horses that could fill the ...
New trial data suggest azacitidine-venetoclax may rival 7+3 in AML, shifting induction toward targeted, less toxic combinations.
Both CV mortality and major bleeding were rarer when antiplatelets weren’t added, with no tradeoff in ischemic events.
I am a 74-year-old male, and for the past two years, I have been unable to rid myself of a stubborn case of jock itch. I have ...
Lifetime earnings, career interruptions and caregiving responsibilities continue to shape retirement outcomes for women in ...
As Father Pham listed job after job, I couldn’t believe how he fit everything in. He has an “irregular sleep schedule,” he ...
Advances in network science, artificial intelligence, and clinician networks may shift medical decisions from individual doctors to groups—and even AI models—at scale.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results